SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 346.57 |
| Enterprise Value ($M) | 255.41 |
| Book Value ($M) | 198.08 |
| Book Value / Share | 21.30 |
| Price / Book | 1.75 |
| NCAV ($M) | 112.12 |
| NCAV / Share | 12.06 |
| Price / NCAV | 3.09 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.36 |
| Return on Assets (ROA) | -0.78 |
| Return on Equity (ROE) | -1.15 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.28 |
| Current Ratio | 13.28 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 163.63 |
| Assets | 249.59 |
| Liabilities | 51.51 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -84.53 |
| Net Income | -81.17 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -67.28 |
| Cash from Investing | 11.16 |
| Cash from Financing | 187.76 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Artal International S.C.A. | 4.50 | -1.32 | |
| 13G | Deep Track Capital, LP | 7.70 | ||
| 13D/A | New Enterprise Associates 17, L.P. | 11.80 | 1.66 | |
| 13G/A | Cormorant Asset Management, LP | 6.61 | -22.09 | |
| 13G | Eventide Asset Management, Llc | 6.83 | ||
| 13G/A | Citadel Advisors Llc | 6.60 | ||
| 13G | Fmr Llc | 9.09 | ||
| 13G | Platanus Investment LLC | 6.80 | ||
| 13D | Atlas Venture Fund XI, L.P. | 11.80 | ||
| 13G | Point72 Asset Management, L.P. | 6.80 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 11,171 | 44,677 | 25.00 | |
| 11,614 | 54,056 | 21.49 | |
| 10,338 | 54,724 | 18.89 | |
| 9,333 | 70,798 | 13.18 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KA – Kineta, Inc. | KALA – KALA BIO, Inc. |
| KPRX – Kiora Pharmaceuticals, Inc. | KTRA – Kintara Therapeutics, Inc. |
| KTTA – Pasithea Therapeutics Corp. |
Financial data and stock pages provided by
Fintel.io